假性低醛固酮血症
错义突变
重吸收
激酶
生物
基因
遗传学
丝氨酸苏氨酸激酶
肾单位
突变
细胞生物学
肾
蛋白激酶A
作者
Frederick H. Wilson,Sandra Disse-Nicodème,Keith A. Choate,Kazuhiko Ishikawa,Carol Nelson‐Williams,Isabelle Desitter,Murat Günel,David V. Milford,Graham Lipkin,Jean‐Michel Achard,Morgan Feely,Bertrand Dussol,Yvon Berland,Robert J. Unwin,Haim Mayan,David B. Simon,Zvi Farfel,Xavier Jeunemaı̂tre,Richard P. Lifton
出处
期刊:Science
[American Association for the Advancement of Science (AAAS)]
日期:2001-08-10
卷期号:293 (5532): 1107-1112
被引量:1461
标识
DOI:10.1126/science.1062844
摘要
Hypertension is a major public health problem of largely unknown cause. Here, we identify two genes causing pseudohypoaldosteronism type II, a Mendelian trait featuring hypertension, increased renal salt reabsorption, and impaired K + and H + excretion. Both genes encode members of the WNK family of serine-threonine kinases. Disease-causing mutations in WNK1 are large intronic deletions that increase WNK1 expression. The mutations in WNK4 are missense, which cluster in a short, highly conserved segment of the encoded protein. Both proteins localize to the distal nephron, a kidney segment involved in salt, K + , and pH homeostasis. WNK1 is cytoplasmic, whereas WNK4 localizes to tight junctions. The WNK kinases and their associated signaling pathway(s) may offer new targets for the development of antihypertensive drugs.
科研通智能强力驱动
Strongly Powered by AbleSci AI